|   | |
| Company type | Public | 
|---|---|
| Nasdaq:  PAHC S&P 600 Component | |
| Industry | Animal health and nutrition | 
| Headquarters | Teaneck, New Jersey, U.S. | 
| Key people | [1] [2] | 
| Revenue |  US$833 million (2021) [3] | 
| Number of employees | 1,400 [4] [5] | 
| Website | pahc | 
Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. [6] [7] The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. [8] The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. [6] It is incorporated in Delaware. [9]
The company was founded in 1946 as Phillip Brothers Chemicals, Inc. [10] [11]
In 1974, it acquired Koffolk, an animal nutrition company based in Israel. [10]
In 2000, Pfizer sold its medicated feed additives business to Phibro Animal Health [12] [10]
In 2003, the company changed its name from Phillip Brothers Chemicals to Phibro Animal Health. [13] [10]
In 2009, the company acquired Baltzell US mineral nutrition business and ABIC Laboratories, a vaccine maker from Israel. [14] [10]
In 2014, Phibro Animal Health held an initial public offering and became listed on the Nasdaq. [15] [16]
In 2018, the company established a biotech facility in Sligo, Ireland producing animal health vaccines. It became the company's first manufacturing plant in Europe. [4] [5]
{{cite web}}: |first= has generic name (help)[ permanent dead link ]